차세대 시퀀싱 샘플 조제 시장 : 워크플로우, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Next-Generation Sequencing Sample Preparation Market was valued at USD 4.89 billion in 2023, expected to reach USD 5.63 billion in 2024, and is projected to grow at a CAGR of 15.08%, to USD 13.09 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation is a critical component of the genomic sequencing process, entailing the conversion of native biological samples into a library of nucleic acids suitable for subsequent sequencing. This preparation is fundamental because effective sample processing ensures the accuracy and efficiency of the NGS techniques, widely utilized in genomic research, diagnostics, and personalized medicine. The market's end-use scope encompasses clinical diagnostics, pharmaceutical and biotechnology companies, academic research institutions, and agrigenomics, each leveraging NGS for diverse applications such as disease diagnosis, drug discovery, or crop improvement. Key growth drivers include the increasing demand for personalized medicine, significant advancements in NGS technologies, and a substantial reduction in sequencing costs. Additionally, the growing prevalence of genetic disorders and cancer has heightened the need for advanced NGS testing, fuelling market growth. However, this growth is met with challenges such as the complexity of the NGS data analysis, high initial setup costs, and a shortage of skilled professionals adept in bioinformatics. Potential opportunities lie in the integration of artificial intelligence and machine learning to streamline data analysis, improve sequencing accuracy, and develop innovative sample preparation kits that minimize hands-on time and maximize throughput. For businesses, investing in collaborations with academic and research institutions can pave the way for further innovation. Exploring automation in sample preparation can drastically reduce manual errors and time required, presenting another avenue for growth. Market limitations include stringent regulatory requirements and ethical concerns surrounding data privacy, demanding ongoing industry vigilance. To thrive, market players should prioritize R&D investment in areas like microfluidics and synthetic biology, crucial for optimizing NGS processes. Overall, the NGS sample preparation market is characterized by rapid technological advancements and a dynamic competitive landscape, necessitating agility and strategic innovation to capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next-Generation Sequencing Sample Preparation Market

The Next-Generation Sequencing Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing automation in NGS sample preparation
  • Government & private organizations support for large-scale sequencing
  • Improved reimbursement outline for NGS-based diagnostic tests
• Market Restraints
  • Ethical concerns associated with NGS sample
• Market Opportunities
  • Widening application of NGS in agriculture
  • New technological advancements in next-generation sequencing sample preparation
• Market Challenges
  • Limitations in accurate NGS sample preparation

Porter's Five Forces: A Strategic Tool for Navigating the Next-Generation Sequencing Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next-Generation Sequencing Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next-Generation Sequencing Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next-Generation Sequencing Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next-Generation Sequencing Sample Preparation Market

A detailed market share analysis in the Next-Generation Sequencing Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next-Generation Sequencing Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next-Generation Sequencing Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next-Generation Sequencing Sample Preparation Market

A strategic analysis of the Next-Generation Sequencing Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Sequencing Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc., Illumina, Inc., Life Technologies Corp., Macrogen, Inc., Pacific Biosciences of California, Inc., Perkin Elmer, Inc., PierianDx, Inc., Qiagen, Quest Diagnostics Incorporated, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Sequencing Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Workflow, market is studied across Automated Library Preparation, Clonal Amplification, NGS Library Preparation Kits, and Semi-Automated Library Preparation.
• Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
• Based on End User, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing automation in NGS sample preparation
    • 5.1.1.2. Government & private organizations support for large-scale sequencing
    • 5.1.1.3. Improved reimbursement outline for NGS-based diagnostic tests
  • 5.1.2. Restraints
    • 5.1.2.1. Ethical concerns associated with NGS sample
  • 5.1.3. Opportunities
    • 5.1.3.1. Widening application of NGS in agriculture
    • 5.1.3.2. New technological advancements in next-generation sequencing sample preparation
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations in accurate NGS sample preparation
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Next-Generation Sequencing Sample Preparation Market, by Workflow

• 6.1. Introduction
• 6.2. Automated Library Preparation
• 6.3. Clonal Amplification
• 6.4. NGS Library Preparation Kits
• 6.5. Semi-Automated Library Preparation

7. Next-Generation Sequencing Sample Preparation Market, by Application

• 7.1. Introduction
• 7.2. Agrigenomics & Forensics
• 7.3. Clinical Investigation
• 7.4. Consumer Genomics
• 7.5. HLA Typing/Immune System Monitoring
• 7.6. Metagenomics, Epidemiology & Drug Development
• 7.7. Oncology
• 7.8. Reproductive Health

8. Next-Generation Sequencing Sample Preparation Market, by End User

• 8.1. Introduction
• 8.2. Academic Research
• 8.3. Clinical Research
• 8.4. Hospitals & Clinics
• 8.5. Pharma & Biotech Entities

9. Americas Next-Generation Sequencing Sample Preparation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Next-Generation Sequencing Sample Preparation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation Sequencing Sample Preparation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. BGI
• 3. Bio-Rad Laboratories, Inc.
• 4. Eurofins Scientific SE
• 5. F. Hoffmann-La Roche Ltd.
• 6. Foundation Medicine, Inc.
• 7. Illumina, Inc.
• 8. Life Technologies Corp.
• 9. Macrogen, Inc.
• 10. Pacific Biosciences of California, Inc.
• 11. Perkin Elmer, Inc.
• 12. PierianDx, Inc.
• 13. Qiagen
• 14. Quest Diagnostics Incorporated
• 15. Thermo Fisher Scientific, Inc.